Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-12-10 to 2025-01-02
Current total value of award: $10316.36
Description: 4566708149!TYSABRI 300 MG/15 ML VIAL 15ML